InsideGov
Congress · Laws

Designer Anabolic Steroid Control Act of 2014

Public Law 113-260 · H.R. 4771 · 113th Congress · began in the House

Signed by Barack Obama (D) on Dec 18, 2014 · Crime and Law Enforcement

Sponsor: Rep. Joseph Pitts (R-PA-16)

Cosponsors (6): Rep. Frank Pallone,

Passage votes

  • HouseVoice vote
  • SenateUnanimous consent
Data notes

The final version of the law, as each chamber passed it. A chamber that passed it by voice vote or unanimous consent has no count. “Method not stated” means the record does not say how the chamber voted. Where the record has a member-by-member vote, the “Who voted for it” section shows who voted yea.

Report a correction

Summary

The Congressional Research Service’s plain-language summary of what the law does.

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

Committees

The committees the bill was sent to, and what each did with it.

Data notes

A committee links to its page only where it exists in the current Congress; older and renamed committees are named without a link.

Report a correction

Related bills

1 bill the Library of Congress relates to this one.

  • S. 2012Related bill

    Designer Anabolic Steroid Control Act of 2014

Data notes

Related bills are identified by the Congressional Research Service, the House and the Senate: companion and identical bills, bills with similar text, bills that were folded into this law, and rules that brought it to the floor. A bill that is itself a public law in this site’s data links here; the others link to Congress.gov.

Report a correction

Timeline

From introduction to signing, newest first: the committees, the floor and the president. 27 actions.

  1. Dec 18, 2014Became lawBecame law · Became Public Law No: 113-260.
  2. Became lawBecame law · Signed by President.
  3. Dec 13, 2014FloorFloor · Presented to President.
  4. Dec 12, 2014FloorFloor · Message on Senate action sent to the House.
  5. Dec 11, 2014FloorFloor · Passed Senate without amendment by Unanimous Consent.
  6. CommitteeCommittee · Senate Committee on the Judiciary discharged by Unanimous Consent.
  7. Sep 16, 2014CommitteeCommittee · Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  8. Sep 15, 2014FloorFloor · Motion to reconsider laid on the table Agreed to without objection.
  9. FloorFloor · On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  10. FloorFloor · DEBATE - The House proceeded with forty minutes of debate on H.R. 4771.
  11. FloorFloor · Considered under suspension of the rules.
  12. FloorFloor · Mr. Pitts moved to suspend the rules and pass the bill, as amended.
  13. CalendarCalendar · Placed on the Union Calendar, Calendar No. 434.
  14. CommitteeCommittee · Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II.
  15. CommitteeCommittee · Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.
  16. Sep 10, 2014CommitteeCommittee · Ordered to be Reported (Amended) by Voice Vote.
  17. CommitteeCommittee · Committee Consideration and Mark-up Session Held.
  18. Sep 9, 2014CommitteeCommittee · Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
  19. Jul 21, 2014CommitteeCommittee · Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  20. Jul 15, 2014CommitteeCommittee · Ordered to be Reported (Amended) by Voice Vote.
  21. CommitteeCommittee · Committee Consideration and Mark-up Session Held.
  22. Jul 14, 2014CommitteeCommittee · Committee Consideration and Mark-up Session Held.
  23. Jun 19, 2014CommitteeCommittee · Forwarded by Subcommittee to Full Committee by Voice Vote .
  24. CommitteeCommittee · Subcommittee Consideration and Mark-up Session Held.
  25. May 30, 2014CommitteeCommittee · Referred to the Subcommittee on Health.
  26. May 29, 2014CommitteeCommittee · Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  27. IntroducedIntroduced · Introduced in House
Data notes

Every action the Library of Congress lists for the bill, from introduction to signing, plus the dated committee hearings. The source lists many steps twice (the chamber’s own entry and the Library of Congress copy, or a presidential and a became-law entry with the same words); those are shown once. Amendments are listed in their own section.

Report a correction

Amendments

No amendments to this bill are on record.

Data notes

Amendments offered to this bill in either chamber, as the Library of Congress records them: each with a status read from its last recorded step: agreed to, rejected, withdrawn, ruled out of order, fell with another amendment, or offered with no vote recorded (most Senate amendments are only ever offered). The wording of each amendment is the source’s. Amendments to amendments and amendments to other bills are not listed.

Report a correction

Official record

The bill’s full text is on Congress.gov. Data through Oct 7, 2026.